Literature DB >> 9276017

Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease.

J N Domínguez1, S López, J Charris, L Iarruso, G Lobo, A Semenov, J E Olson, P J Rosenthal.   

Abstract

Acridinediones have previously been shown to have potent antimalarial activity. A series of sulfur isosteres of acridinediones have been synthesized and evaluated for their inhibition of the Plasmodium falciparum cysteine protease falcipain and for their antimalarial activity. A number of these phenothiazines inhibited falcipain and demonstrated activity against cultured P. falciparum parasites at low micromolar concentrations. We propose that the compounds exerted their antimalarial effects by two mechanisms, one of which involves the inhibition of falcipain and a consequent block in parasite degradation of hemoglobin. These compounds and related phenothiazines are worthy of further study as potential antimalarial agents.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276017     DOI: 10.1021/jm970266p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Calcium-dependent proteolytic activity of a cysteine protease caldonopain is detected during Leishmania infection.

Authors:  Runu Dey; Jharna Bhattacharya; Salil C Datta
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

2.  Novel anti-plasmodial hits identified by virtual screening of the ZINC database.

Authors:  Grace Mugumbate; Ana S Newton; Philip J Rosenthal; Jiri Gut; Rui Moreira; Kelly Chibale; Rita C Guedes
Journal:  J Comput Aided Mol Des       Date:  2013-10-25       Impact factor: 3.686

Review 3.  Proteases of malaria parasites: new targets for chemotherapy.

Authors:  P J Rosenthal
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

4.  The antidiabetic compound 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L., demonstrates significant antitumor potential against human breast cancer cells.

Authors:  Ying Gao; Renbin Huang; Yixuan Gong; Hyo Sim Park; Qingwei Wen; Nadin Marwan Almosnid; Uma D Chippada-Venkata; Najlaa Abdulrhman Hosain; Eric Vick; Anthony Farone; Elliot Altman
Journal:  Oncotarget       Date:  2015-09-15

5.  Anti-Inflammatory Properties of the Enaminone E121 in the Dextran Sulfate Sodium (DSS) Colitis Model.

Authors:  Maitham A Khajah; Kethireddy V Ananthalakshmi; Ivan Edafiogho
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

6.  In silico Guided Drug Repurposing: Discovery of New Competitive and Non-competitive Inhibitors of Falcipain-2.

Authors:  Lucas N Alberca; Sara R Chuguransky; Cora L Álvarez; Alan Talevi; Emir Salas-Sarduy
Journal:  Front Chem       Date:  2019-08-06       Impact factor: 5.221

7.  An antiviral mechanism of nitric oxide: inhibition of a viral protease.

Authors:  M Saura; C Zaragoza; A McMillan; R A Quick; C Hohenadl; J M Lowenstein; C J Lowenstein
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

8.  Synthesis and in vitro antiproliferative activity of novel 12(H)-quino[3,4-b][1,4]benzothiazine derivatives.

Authors:  Andrzej Zięba; Małgorzata Latocha; Aleksander Sochanik
Journal:  Med Chem Res       Date:  2012-12-24       Impact factor: 1.965

9.  2-(3,4-dihydro-4-oxothieno[2,3-d]pyrimidin-2-ylthio) acetamides as a new class of falcipain-2 inhibitors. 3. design, synthesis and biological evaluation.

Authors:  Jin Zhu; Tong Chen; Jie Liu; Ruoqun Ma; Weiqiang Lu; Jin Huang; Honglin Li; Jian Li; Hualiang Jiang
Journal:  Molecules       Date:  2009-02-16       Impact factor: 4.411

10.  2-amido-3-(1H-indol-3-yl)-N-substituted-propanamides as a new class of falcipain-2 inhibitors. 1. Design, synthesis, biological evaluation and binding model studies.

Authors:  Jin Zhu; Tong Chen; Lili Chen; Weiqiang Lu; Peng Che; Jin Huang; Honglin Li; Jian Li; Hualiang Jiang
Journal:  Molecules       Date:  2009-01-21       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.